Bupropion metabolism by human placenta
- 1 June 2010
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 79 (11), 1684-1690
- https://doi.org/10.1016/j.bcp.2010.01.026
Abstract
No abstract availableKeywords
Funding Information
- NIDA (RO1DA024094)
This publication has 52 references indexed in Scilit:
- Transplacental transfer and metabolism of bupropionThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRODrug Metabolism and Disposition, 2004
- Human Carbonyl Reduction Pathways and a Strategy for Their Study In VitroDrug Metabolism Reviews, 2004
- Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brainNeuropharmacology, 2003
- Aromatase Is the Major Enzyme Metabolizing Buprenorphine in Human PlacentaThe Journal of pharmacology and experimental therapeutics, 2003
- Purification, characterization and NNK carbonyl reductase activities of 11β-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogenChemico-Biological Interactions, 2003
- Nicotine patches for pregnant smokers: a randomized controlled studyObstetrics & Gynecology, 2000
- Drug Interactions with Tobacco SmokingClinical Pharmacokinetics, 1999
- Selective inhibition of human type 1 11β‐hydroxysteroid dehydrogenase by synthetic steroids and xenobioticsFEBS Letters, 1998
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994